https://idataresearch.com/wp-content/uploads/2019/10/ReportIcon-Kidneys-MS.jpg

Urology Market Size, Share & Trends Analysis | Australia | 2020-2026 | MedSuite | Includes: Urinary Incontinence Market, Pelvic Organ Prolapse Repair Market, and 3 more

  • Year: 2020
  • Scope: 10 Years
  • Region: Australia
  • Pages: 387
  • Published Date: 10/15/2019
  • Type: MedSuite

In 2020, the Australian urology market size was valued at nearly $72 million, with over 167,000 yearly urological procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3% to reach nearly $89 million in 2026.

Throughout this medical market research, we analyzed 31 urology companies across Australia and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all of the Australian Urological Device market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Urology Procedure Volumes
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Competitive Analysis with Market Shares for Each Segment
  • Market Drivers & Limiters for Each Urological Device market
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Market Value and Industry Trends

The BPH treatment market, and the stone management device market, accounted for the majority of the total market value in 2019. The growth in these two segments is driven by the stable demand for related procedures, the growing prevalence of prostatic and kidney diseases, and the premium prices for lasers and lithotripters.

Australia Urological Devices Market Size by Segment, 2016-2026

The stable growth across the market is driven by the continuing adoption of new technologies, focused on the largest and the growing areas of the market. The UroLift® market has experienced rapid growth since its launch in Australia in 2012 and its reimbursement coverage in 2013.

The female urinary incontinence market, which represented nearly one-third of the combined incontinence management device market, is undergoing structural changes, due to regulatory and reimbursement changes regarding transvaginal tape and mini-slings. Both devices are currently banned in Australia.

Competitive Analysis

Australia Urology Market LeadersBy 2020, the leading competitor in the Australian urological device market was Boston Scientific. The company held the leading positions in the pelvic organ prolapse repair market, stone management device market, and BPH treatment device market. The company’s leading position is attributed to its established products, including men’s health and prostate health businesses. The acquisition of NxThera and its Rezūm® system in 2018 provided Boston Scientific’s sole presence in the emerging Rezūm® market in Australia.

Coloplast was the second-leading competitor in the urology market in Australia. This was attributed to the company’s leading share in the urinary incontinence market, primarily driven by the catheter segment, as well as its notable share of pelvic organ prolapse repair and its leading share in erectile dysfunction treatment.

Olympus was the third-leading competitor in the Australian urological device market by 2020. This was attributed to its second-leading position in the BPH treatment market and a notable presence in the stone management device market. Olympus operates a urology/gynecology business unit (UGBU), the growth of which is supported by the company’s strength in the gastrointestinal business and in surgical device technologies.

Segments Covered

Click on each title to view detailed market segmentation.

  • Procedure Volumes for Urological Devices – MedPro – The complete procedural analysis of the urological device market in Australia, which includes Incontinence Sling Implantation, Artificial Urinary Sphincter Implantation, Urethral Bulking, Transvaginal Tape Incontinence Sling, Transobturator Incontinence Sling, Single-Incision Incontinence Sling, and many other procedures for each of the market segments.
  • Urinary Incontinence Market – MedCore – This market is further segmented into market segments, such as Urinary Catheters, Urethral Bulking Agents, and Incontinence Management Devices.
  • Pelvic Organ Prolapse Repair Market – MedCore – The market is comprised of the segments for Transvaginal and Sacrocolpopexy Meshes.
  • Stone Management Market – MedCore – This market is categorized by Device Type into ESWL Equipment, ISWL Equipment, Holmium Lasers, Stone Fragment Retrieval Device, Ureteral Stent, and Ureteral Guidewire market segments.
  • Benign Prostatic Hyperplasia (BPH) Treatment Market – MedCore – This market is segmented by Device Type, including Transurethral Resection of Prostate, Laser BPH, UroLift, and Rezūm device market segments.
  • Erectile Dysfunction Market – MedCore – The market is comprised of the segments for Inflatable, Malleable and Vacuum devices.

Detailed Market Segmentation

Australia Urology Market Segmentation - p1Australia Urology Market Segmentation - p2

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

FREE Sample Report

TABLE OF CONTENTS FOR THE AUSTRALIA UROLOGICAL DEVICE MARKET REPORT SUITE
TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XIX
EXECUTIVE SUMMARY 1
AUSTRALIA UROLOGICAL DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 6
MARKET DEVELOPMENTS 7
PROCEDURE NUMBERS 8
MARKETS INCLUDED 9
VERSION HISTORY 10
RESEARCH METHODOLOGY 11
Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 14
Step 3: Preparation for Interviews & Questionnaire Design 16
Step 4: Performing Primary Research 17
Step 5: Research Analysis: Establishing Baseline Estimates 19
Step 6: Market Forecast and Analysis 20
Step 7: Identify Strategic Opportunities 22
Step 8: Final Review and Market Release 23
Step 9: Customer Feedback and Market Monitoring 24
DISEASE OVERVIEW
2.1 BASIC ANATOMY 25
2.1.1 Urinary System 25
2.1.1.1 Male Urinary System 26
2.1.1.2 Female Urinary System 27
2.2 DISEASE TREATMENT AND DIAGNOSTICS 28
2.2.1 Benign Prostatic Hyperplasia 28
2.2.2 Urinary Incontinence 29
2.2.3 Urinary Tract Infections 31
2.2.4 Kidney Stones 32
2.2.5 Bladder Prolapse 34
2.2.6 Overactive Bladder 35
2.2.7 Prostatitis 36
2.2.8 Erectile Dysfunction 38
2.2.9 Cancer 39
2.2.9.1 Prostate Cancer 39
2.2.9.2 Bladder Cancer 40
2.2.10 Indications for Pelvic Organ Prolapse Repair 41
2.3 PATIENT DEMOGRAPHICS 42
PRODUCT ASSESSMENT
3.1 INTRODUCTION 44
3.2 PRODUCT PORTFOLIOS 44
3.2.1 Urinary Incontinence 44
3.2.1.1 Urinary Catheters 44
3.2.1.1.1 Intermittent Catheters 44
3.2.1.1.2 Foley Catheters 45
3.2.1.1.3 Male External Catheters 46
3.2.1.2 Urethral Bulking Agents 47
3.2.1.3 Incontinence Management Devices 48
3.2.1.3.1 Female Incontinence Slings 48
3.2.1.3.2 Male Implantable Devices 49
3.2.1.4 Urine Bags 51
3.2.1.4.1 Leg Bags 51
3.2.1.4.2 Night Bags 51
3.2.2 Pelvic Organ Prolapse Repair 56
3.2.2.1 Autologous Tissue as an Alternative to Vaginal Mesh 57
3.2.2.2 Product Matrix for Pelvic Organ Prolapse Repair 58
3.2.3 Stone Management 59
3.2.3.1 ESWL Equipment 59
3.2.3.2 ISWL Equipment 60
3.2.3.3 Holmium Lasers 60
3.2.3.4 Stone Fragment Retrieval Devices 61
3.2.3.5 Ureteral Stents 61
3.2.4 BPH Treatment 65
3.2.4.1 TURP 65
3.2.4.2 TUMT 66
3.2.4.3 TUNA 66
3.2.4.4 Prostatic Stents 67
3.2.4.5 Laser BPH 68
3.2.4.5.1 Photoselective Vaporization of the Prostate (PVP) 69
3.2.4.5.2 Laser Vaporization of the Prostate 70
3.2.4.5.3 Laser Ablation of the Prostate 71
3.2.4.5.4 Laser Resection of the Prostate 71
3.2.4.5.5 Laser Enucleation of the Prostate 72
3.2.5 Erectile Dysfunction 74
3.2.5.1 Penile Implants 74
3.2.5.1.1 Inflatable 74
3.2.5.1.2 Malleable 75
3.2.5.2 Vacuum 75
3.3 REGULATORY ISSUES AND RECALLS 77
3.3.1 Boston Scientific 77
3.3.1.1 Stone Management 77
3.3.1.2 Nephrostomy 79
3.3.2 C. R. Bard (Becton Dickinson) 80
3.3.2.1 Urinary Incontinence 80
3.3.2.2 Stone Management 85
3.3.2.3 Urological Endoscopes 85
3.3.2.4 Prostate Cancer Treatment 85
3.3.2.5 Nephrostomy 86
3.3.3 Coloplast 883
.3.3.1 Urinary Catheter 88
3.3.3.2 Erectile Dysfunction 88
3.3.4 Cook Medical 89
3.3.4.1 Stone Management 89
3.3.4.2 Nephrostomy 90
3.3.5 Elekta 92
3.3.5.1 Prostate Cancer Treatment 92
3.3.6 Karl Storz 93
3.3.6.1 Urological Endoscopes 93
3.3.7 Olympus 94
3.3.7.1 Urological Endoscopes 94
3.4 CLINICAL TRIALS 96
3.4.1 Boston Scientific 96
3.4.1.1 Urinary Incontinence 96
3.4.1.2 BPH Treatment 97
3.4.1.3 Urological endoscopes 98
3.4.1.4 Nephrostomy 99
3.4.1.5 Erectile Dysfunction 100
3.4.2 C. R. Bard (Becton Dickinson) 101
3.4.2.1 Urinary Incontinence 101
3.4.2.2 Prostate Cancer Treatment 103
3.4.3 Coloplast 104
3.4.3.1 Urinary Incontinence 104
3.4.4 Cook Medical 1073.4.4.1 Nephrostomy 107
3.4.5 Elekta 1093.4.5.1 Prostate Cancer Treatment 109
3.4.6 Ethicon 111
3.4.6.1 Urinary Incontinence 111
3.4.7 Karl Storz 113
3.4.7.1 Stone Management 113
3.4.7.2 Urological Endoscopes 115
3.4.8 Laborie 118
3.4.8.1 Urodynamics 118
3.4.9 Medline 120
3.4.9.1 Urinary Incontinence 120
3.4.10 Olympus 121
3.4.10.1 Stone Management 121
3.4.10.2 BPH Treatment 122
3.4.10.3 Urological Endoscopes 123
AUSTRALIA UROLOGICAL DEVICE MARKET OVERVIEW
4.1 INTRODUCTION 125
4.2 CURRENCY EXCHANGE RATE 126
4.3 MARKET OVERVIEW 127
4.4 TREND ANALYSIS BY SEGMENT 133
4.5 DRIVERS AND LIMITERS 136
4.5.1 Market Drivers 136
4.5.2 Market Limiters 137
4.6 COMPETITIVE MARKET SHARE ANALYSIS 140
4.7 MERGERS AND ACQUISITIONS 147
4.8 COMPANY PROFILES 149
4.8.1 Boston Scientific 149
4.8.2 C. R. Bard (Becton Dickinson) 151
4.8.3 Coloplast 153
4.8.4 Cook Medical 154
4.8.5 Ethicon 155
4.8.6 Karl Storz 156
4.8.7 Laborie 157
4.8.8 Olympus 158
4.9 SWOT ANALYSIS 160
4.9.1 Boston Scientific 161
4.9.2 C. R. Bard (Becton Dickinson) 163
4.9.3 Coloplast 165
4.9.4 Cook Medical 166
4.9.5 Ethicon 168
4.9.6 Karl Storz 169
4.9.7 Laborie 170
4.9.8 Olympus 171
PROCEDURE NUMBERS
5.1 PROCEDURE OVERVIEW 173
5.2 URINARY INCONTINENCE PROCEDURES 180
5.2.1 Male Incontinence Management Procedures 182
5.2.2 Female Incontinence Management Procedures 185
5.3 PELVIC ORGAN PROLAPSE REPAIR 188
5.4 STONE MANAGEMENT PROCEDURES 190
5.4.1 ESWL Procedures 192
5.4.2 Transurethral Procedures 194
5.4.3 Ureteral Stent Placement Procedures 196
5.4.4 PCNL Procedures 198
5.5 BPH PROCEDURES 200
5.5.1 BPH Procedures 201
5.5.2 Prostatectomy Procedures 203
5.6 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 205
URINARY INCONTINENCE DEVICE MARKET
6.1 INTRODUCTION 208
6.2 MARKET OVERVIEW 209
6.3 MARKET ANALYSIS AND FORECAST 214
6.3.1 Total Urinary Catheter Market 214
6.3.1.1 Intermittent Catheter Market 217
6.3.1.2 Foley Catheter Market 219
6.3.1.3 Male External Catheter Market 221
6.3.2 Total Urethral Bulking Agent Market 223
6.3.2.1 Male Urethral Bulking Agent Market 227
6.3.2.2 Female Urethral Bulking Agent Market 229
6.3.3 Total Incontinence Management Device Market 231
6.3.3.1 Total Female Incontinence Sling Market 234
6.3.3.1.1 Transvaginal Tape Female Incontinence Sling Market 240
6.3.3.1.2 Transobturator Female Incontinence Sling Market 242
6.3.3.1.3 Single-Incision Female Incontinence Sling Market 244
6.3.3.2 Total Male Implantable Incontinence Device Market 246
6.3.3.2.1 Male Incontinence Sling Market 251
6.3.3.2.2 Male Artificial Urinary Sphincter Market 253
6.4 DRIVERS AND LIMITERS 255
6.4.1 Market Drivers 255
6.4.2 Market Limiters 255
6.5 COMPETITIVE MARKET SHARE ANALYSIS 258
PELVIC ORGAN PROLAPSE REPAIR DEVICE MARKET
7.1 INTRODUCTION 264
7.2 MARKET OVERVIEW 268
7.3 MARKET ANALYSIS AND FORECAST 273
7.3.1 Total Pelvic Organ Prolapse Repair Device Market 273
7.3.2 Transvaginal Mesh Market 276
7.3.3 Sacrocolpopexy Mesh Market 279
7.4 DRIVERS AND LIMITERS 281
7.4.1 Market Drivers 281
7.4.2 Market Limiters 281
7.5 COMPETITIVE MARKET SHARE ANALYSIS 283
STONE MANAGEMENT DEVICE MARKET
8.1 INTRODUCTION 287
8.2 MARKET OVERVIEW 290
8.3 MARKET ANALYSIS AND FORECAST 296
8.3.1 ESWL Equipment Market 296
8.3.2 ISWL Equipment Market 299
8.3.3 Total Holmium Laser Market 301
8.3.3.1 Holmium Laser Equipment Market 304
8.3.3.2 Holmium Laser Fiber Market 306
8.3.4 Total Stone Fragment Retrieval Device Market 309
8.3.4.1 Nitinol Stone Fragment Retrieval Device Market 314
8.3.4.2 Stainless Steel Stone Fragment Retrieval Device Market 316
8.3.5 Ureteral Stent Market 318
8.3.6 Ureteral Guidewire Market 320
8.4 DRIVERS AND LIMITERS 322
8.4.1 Market Drivers 322
8.4.2 Market Limiters 323
8.5 COMPETITIVE MARKET SHARE ANALYSIS 325
BPH TREATMENT DEVICE MARKET
9.1 INTRODUCTION 331
9.1.1 Treatments 331
9.1.2 Comparison of TURP and Laser BPH Procedures 333
9.1.3 Emerging Technologies 333
9.2 MARKET OVERVIEW 335
9.3 MARKET ANALYSIS AND FORECAST 340
9.3.1 Total TURP Market 340
9.3.1.1 Monopolar Electrode Market 343
9.3.1.2 Bipolar Electrode Market 345
9.3.2 Total Laser BPH Market 347
9.3.2.1 Laser BPH Equipment Market 350
9.3.2.2 Laser BPH Fiber Market 352
9.3.3 UroLift® Market 354
9.3.4 Rezūm® Market 356
9.4 DRIVERS AND LIMITERS 358
9.4.1 Market Limiters 359
9.5 COMPETITIVE MARKET SHARE ANALYSIS 362
ERECTILE DYSFUNCTION DEVICE MARKET
10.1 INTRODUCTION 366
10.1.1 Low Testosterone Pharmaceutical Delivery 367
10.2 MARKET OVERVIEW 368
10.3 MARKET ANALYSIS AND FORECAST 373
10.3.1 Inflatable Erectile Dysfunction Device Market 373
10.3.2 Malleable Erectile Dysfunction Device Market 376
10.3.3 Vacuum Erection Device Market 378
10.4 DRIVERS AND LIMITERS 380
10.4.1 Market Drivers 380
10.4.2 Market Limiters 380
10.5 COMPETITIVE MARKET SHARE ANALYSIS 382
ABBREVIATIONS
The Urology Market Report Suite | Australia | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:
  • Applied Medical
  • BARD
  • Bonro Medical
  • Boston Scientific
  • Coloplast
  • Contura
  • ConvaTek
  • Cook Medical
  • Dornier MedTech
  • EDAP TMS
  • EMS
  • Endo Personal Care
  • Endotherapeutics
  • Getz Healthcare
  • High Tech Medical
  • Hollister
  • Johnson & Johnson
  • Karl Storz
  • KESSEL Medintim
  • Laborie
  • Lamidey Noury
  • Lumenis
  • Medtronic
  • Neogenix
  • Olympus
  • Richard Wolf
  • Siemens
  • Stryker
  • Surgical Implants
  • Teleflex
  • Zephyr Surgical Implants

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology